Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CXT - US2244411052 - Common Stock

49.98 USD
+0.57 (+1.15%)
Last: 1/9/2026, 8:04:00 PM
49.98 USD
0 (0%)
After Hours: 1/9/2026, 8:04:00 PM
Fundamental Rating

5

CXT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While CXT has a great profitability rating, there are quite some concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CXT.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CXT was profitable.
CXT had a positive operating cash flow in the past year.
Each year in the past 5 years CXT has been profitable.
Each year in the past 5 years CXT had a positive operating cash flow.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

CXT's Return On Assets of 5.30% is fine compared to the rest of the industry. CXT outperforms 71.77% of its industry peers.
CXT has a better Return On Equity (12.74%) than 79.84% of its industry peers.
CXT has a Return On Invested Capital of 8.69%. This is in the better half of the industry: CXT outperforms 78.23% of its industry peers.
CXT had an Average Return On Invested Capital over the past 3 years of 13.27%. This is above the industry average of 9.00%.
The last Return On Invested Capital (8.69%) for CXT is well below the 3 year average (13.27%), which needs to be investigated, but indicates that CXT had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.69%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

CXT's Profit Margin of 9.80% is amongst the best of the industry. CXT outperforms 82.26% of its industry peers.
In the last couple of years the Profit Margin of CXT has declined.
Looking at the Operating Margin, with a value of 17.59%, CXT belongs to the top of the industry, outperforming 92.74% of the companies in the same industry.
CXT's Operating Margin has been stable in the last couple of years.
CXT has a Gross Margin of 43.20%. This is in the better half of the industry: CXT outperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of CXT has remained more or less at the same level.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
CXT has more shares outstanding than it did 1 year ago.
CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.08 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CXT has a Altman-Z score of 2.08. This is in the lower half of the industry: CXT underperforms 69.35% of its industry peers.
CXT has a debt to FCF ratio of 6.27. This is a slightly negative value and a sign of low solvency as CXT would need 6.27 years to pay back of all of its debts.
CXT has a Debt to FCF ratio (6.27) which is in line with its industry peers.
A Debt/Equity ratio of 0.89 indicates that CXT is somewhat dependend on debt financing.
The Debt to Equity ratio of CXT (0.89) is worse than 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.08
ROIC/WACC0.93
WACC9.37%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.26 indicates that CXT should not have too much problems paying its short term obligations.
The Current ratio of CXT (1.26) is worse than 81.45% of its industry peers.
CXT has a Quick Ratio of 1.26. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.94, CXT is not doing good in the industry: 81.45% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CXT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.72%.
CXT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.61% yearly.
The Revenue has grown by 9.30% in the past year. This is quite good.
Measured over the past years, CXT shows a small growth in Revenue. The Revenue has been growing by 3.39% on average per year.
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%

3.2 Future

The Earnings Per Share is expected to grow by 7.04% on average over the next years.
The Revenue is expected to grow by 7.20% on average over the next years.
EPS Next Y-4.27%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
EPS Next 5YN/A
Revenue Next Year9.22%
Revenue Next 2Y7.97%
Revenue Next 3Y7.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.53, which indicates a correct valuation of CXT.
CXT's Price/Earnings ratio is rather cheap when compared to the industry. CXT is cheaper than 90.32% of the companies in the same industry.
CXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.19.
With a Price/Forward Earnings ratio of 10.95, the valuation of CXT can be described as very reasonable.
91.13% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
CXT is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.53
Fwd PE 10.95
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

88.71% of the companies in the same industry are more expensive than CXT, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 87.90% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.63
EV/EBITDA 9.21
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

CXT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.38%
EPS Next 3Y7.04%

5

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.44%. Purely for dividend investing, there may be better candidates out there.
In the last 3 months the price of CXT has falen by -23.78%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 0.47, CXT pays a better dividend. On top of this CXT pays more dividend than 91.94% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 1.94, CXT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.44%

5.2 History

The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CXT pays out 24.82% of its income as dividend. This is a sustainable payout ratio.
The dividend of CXT is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP24.82%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (1/9/2026, 8:04:00 PM)

After market: 49.98 0 (0%)

49.98

+0.57 (+1.15%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners114.42%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change1.75%
Market Cap2.87B
Revenue(TTM)1.58B
Net Income(TTM)154.70M
Analysts81.82
Price Target94.28 (88.64%)
Short Float %12.54%
Short Ratio12
Dividend
Industry RankSector Rank
Dividend Yield 1.44%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.92%
PT rev (3m)2.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.89%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.86%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.54%
Valuation
Industry RankSector Rank
PE 12.53
Fwd PE 10.95
P/S 1.82
P/FCF 16.63
P/OCF 13.24
P/B 2.36
P/tB N/A
EV/EBITDA 9.21
EPS(TTM)3.99
EY7.98%
EPS(NY)4.56
Fwd EY9.13%
FCF(TTM)3.01
FCFY6.01%
OCF(TTM)3.78
OCFY7.55%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number43.57
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.69%
ROICexc 9.36%
ROICexgc 34.76%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexgc growth 3Y39.7%
ROICexgc growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score3
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.08
F-Score3
WACC9.37%
ROIC/WACC0.93
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.72%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%10.34%
EPS Next Y-4.27%
EPS Next 2Y3.38%
EPS Next 3Y7.04%
EPS Next 5YN/A
Revenue 1Y (TTM)9.3%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%10.31%
Revenue Next Year9.22%
Revenue Next 2Y7.97%
Revenue Next 3Y7.2%
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year18.99%
EBIT Next 3Y13.2%
EBIT Next 5YN/A
FCF growth 1Y-55.34%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y-48.89%
OCF growth 3Y-8.23%
OCF growth 5YN/A

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 5 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 7 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 7 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 2 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 5 / 10 and the dividend payout ratio is 24.82%.